PCOS Metabolic Guide · Answer guide
Can you have PCOS insulin resistance with normal blood sugar?
Yes. Insulin resistance and abnormal glucose are related but different: the body may initially compensate by producing more insulin. A normal A1C does not answer every metabolic question in PCOS. The international guideline recommends appropriate glucose assessment rather than routine reliance on insulin assays.
Evidence behind this answer
Sources checked November 1, 2026: [1] International PCOS evidence-based guideline recommendations, 2023[2] Monash: international guideline and May 2026 PCOS / PMOS naming update[3] NIDDK: diabetes tests and diagnosis
Why the distinction matters in PCOS
The syndrome involves more than ovarian appearance. Metabolic risk deserves attention even when symptoms first bring someone to care for irregular cycles, acne or hair changes. Insulin resistance is one aspect of the condition, but not every symptom can be attributed to it. People with different body sizes can have clinically relevant risks. A body shape or symptom quiz cannot establish an individual diagnosis.
Which glucose test is most informative?
The international guideline identifies the oral glucose tolerance test as the most accurate assessment of glycemic status in PCOS, regardless of BMI. Fasting glucose or A1C may be considered when it cannot be performed, with reduced accuracy acknowledged. That is a clinical testing recommendation, not an instruction to order every test privately. Pregnancy planning and other circumstances can affect when assessment is needed.
Why routine fasting insulin is not the answer
The guideline notes the limited clinical relevance of currently available insulin assays and does not recommend their routine use in PCOS care. A commercial “optimal insulin” target therefore should not become the sole definition of progress. Glucose assessment, blood pressure, lipids and other aspects of care answer different questions. The relevant plan should connect each measurement with a practical clinical decision.
What to bring to a clinical review
Bring previous test names, results, dates, medications and your main symptoms. Ask what metabolic assessment is appropriate and how often it should be repeated for your risk. In May 2026, the international guideline program announced PMOS as the new name for PCOS; older records and everyday searches still commonly use PCOS. The naming change does not remove the need for individualized assessment.
Related questions
Does normal A1C mean PCOS has no metabolic effects?
No. It is one glucose measure, not a complete assessment of the syndrome or every associated risk.
Should everyone with PCOS have fasting insulin measured?
The international guideline does not recommend routine clinical use of currently available insulin assays.
Sources
General information, not an individual diagnosis or treatment plan. Product-specific approval, risks and eligibility must be checked against the current label and clinical assessment. How we publish · Report a correction